Patent 8386037 was granted and assigned to Cameron Health on February, 2013 by the United States Patent and Trademark Office.
A subcutaneous cardiac device includes a subcutaneous electrode and a housing coupled to the subcutaneous electrode by a lead with a lead wire. The subcutaneous electrode is adapted to be implanted in a frontal region of the patient so as to overlap a portion of the patient's heart.